Effect of Arginase Inhibition on Ischemia-Reperfusion Injury in Patients with Coronary Artery Disease with and without Diabetes Mellitus

BACKGROUND: Arginase competes with nitric oxide synthase for their common substrate L-arginine. Up-regulation of arginase in coronary artery disease (CAD) and diabetes mellitus may reduce nitric oxide bioavailability contributing to endothelial dysfunction and ischemia-reperfusion injury. Arginase i...

Descripción completa

Detalles Bibliográficos
Autores principales: Kövamees, Oskar, Shemyakin, Alexey, Pernow, John
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Public Library of Science 2014
Materias:
Research Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4114552/
https://www.ncbi.nlm.nih.gov/pubmed/25072937
http://dx.doi.org/10.1371/journal.pone.0103260

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4114552/
https://www.ncbi.nlm.nih.gov/pubmed/25072937
http://dx.doi.org/10.1371/journal.pone.0103260

Ejemplares similares